Continue to Site

Medical Design and Outsourcing

View the BIG 100 largest medical device companies in the world listings here

Edwards Lifesciences logo

Edwards Lifesciences

2023 Rank: 23
2022 Rank: 24

Headquarters:
Irvine, California

www.edwards.com

Revenue ($USD) : $5,382,400,000
R&D spend : $945,200,000.00
Employees : 18,300
Fiscal year end : 12/31/22
CEO : Bernard Zovighian CEO

Strong transcatheter aortic valve replacement (TAVR) sales backed 10% year-over-year revenue growth for Edwards Lifesciences during the first half of 2023. In the U.S., improved hospital staffing levels aided TAVR sales, as did the launch of the Sapien 3 Ultra Resilia. The company has upped its full-year sales guidance to between $5.9 billion and $6.1 billion. “Looking beyond 2023, we remain confident that our foundation of innovative therapies along with a differentiated technology pipeline positions us well for continued longer-term success,” said Bernard Zovighian, who took over as CEO for Michael Mussallem in May 2023. –CN

Search Medical Design & Outsourcing